Literature DB >> 8696249

Cannabis use correlates with schizotypy in healthy people.

J H Williams1, N A Wellman, J N Rawlins.   

Abstract

Cannabis use or high scores on self-report schizotypy questionnaires predict an increased risk of developing clinical psychosis. We tested whether cannabis use correlated with schizotypal and other personality traits in 211 healthy adults. Subjects who had used cannabis showed higher scores on schizotypy, borderline and psychoticism scales than never-users. Multivariate analysis, covarying lie scale scores, age and educational level indicated that high schizotypal traits best discriminated subjects who had used cannabis from never-users, whether or not they reported having used other recreational drugs. These results indicate that cannabis use is related to a personality dimension of psychosis-proneness in healthy people.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8696249

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  13 in total

1.  P50 sensory gating and attentional performance.

Authors:  Li Wan; Bruce H Friedman; Nash N Boutros; Helen J Crawford
Journal:  Int J Psychophysiol       Date:  2007-11-01       Impact factor: 2.997

2.  Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Glen P Davis; Michael T Compton; Shuai Wang; Frances R Levin; Carlos Blanco
Journal:  Schizophr Res       Date:  2013-11-05       Impact factor: 4.939

3.  Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy.

Authors:  Anne Schmechtig; Jane Lees; Lois Grayson; Kevin J Craig; Rukiya Dadhiwala; Gerard R Dawson; J F William Deakin; Colin T Dourish; Ivan Koychev; Katrina McMullen; Ellen M Migo; Charlotte Perry; Lawrence Wilkinson; Robin Morris; Steve C R Williams; Ulrich Ettinger
Journal:  Psychopharmacology (Berl)       Date:  2013-02-22       Impact factor: 4.530

Review 4.  Cognition and brain function in schizotypy: a selective review.

Authors:  Ulrich Ettinger; Christine Mohr; Diane C Gooding; Alex S Cohen; Alexander Rapp; Corinna Haenschel; Sohee Park
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

5.  Total exposure duration and proximity of cessation of cannabis use predict severity of sub-clinical psychotic symptoms among former users.

Authors:  Bora Baskak; Kerim Munir; Halise Devrimci Ozguven; Ersin Koc; Gulumser Gedik; Derya Erkan; Cem E Atbasoglu
Journal:  Psychiatry Res       Date:  2012-03-20       Impact factor: 3.222

Review 6.  Cannabis and psychosis/schizophrenia: human studies.

Authors:  Deepak Cyril D'Souza; Richard Andrew Sewell; Mohini Ranganathan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-16       Impact factor: 5.270

7.  Prevalence, correlates, disability, and comorbidity of DSM-IV schizotypal personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions.

Authors:  Attila J Pulay; Frederick S Stinson; Deborah A Dawson; Risë B Goldstein; S Patricia Chou; Boji Huang; Tulshi D Saha; Sharon M Smith; Roger P Pickering; W June Ruan; Deborah S Hasin; Bridget F Grant
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

8.  Associations between past alcohol, cannabis, and cocaine use and current schizotypy among first-degree relatives of patients with schizophrenia and non-psychiatric controls.

Authors:  Michael T Compton; Victoria H Chien; Annie M Bollini
Journal:  Psychiatr Q       Date:  2009-04-25

9.  Visual scan paths in first-episode schizophrenia and cannabis-induced psychosis.

Authors:  Philip J Benson; Ute Leonards; Robert M Lothian; David M St Clair; Marco C G Merlo
Journal:  J Psychiatry Neurosci       Date:  2007-07       Impact factor: 6.186

10.  Association of schizotypy with striatocortical functional connectivity and its asymmetry in healthy adults.

Authors:  Yi Wang; Ulrich Ettinger; Thomas Meindl; Raymond C K Chan
Journal:  Hum Brain Mapp       Date:  2017-10-11       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.